Vaccines, blood, antisera, toxins and cultures in   Pakistan

Exports In 2022, Pakistan exported $906k in Vaccines, blood, antisera, toxins and cultures, making it the 106th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 497th most exported product in Pakistan. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Pakistan are: Zambia ($211k), New Zealand ($189k), Philippines ($184k), United Kingdom ($110k), and Singapore ($56.4k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Pakistan between 2021 and 2022 were New Zealand ($188k), United Kingdom ($106k), and Philippines ($63.7k).

Imports In 2022, Pakistan imported $828M in Vaccines, blood, antisera, toxins and cultures, becoming the 43rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 16th most imported product in Pakistan. Pakistan imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($303M), Belgium ($186M), India ($79.4M), France ($60.3M), and Germany ($46.4M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Pakistan between 2021 and 2022 were Eswatini ($29M), Bahrain ($12.3M), and Germany ($9.29M).